Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04247971 · ClinicalTrials.gov registry record
Pulmonary Inflammation and Microbiome Changes With Bariatric Surgery in Obese Asthma
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 16
- Enrollment target
NCT04247971 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 16 participants.
The verdict
NCT04247971 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to gain understanding of mechanisms whereby bariatric surgery modulates pulmonary inflammation and pulmonary microbiome composition and how these changes direct the pathobiology of human obese asthma.
Interventions
- PROCEDURE Blood draw
- PROCEDURE Sputum collection
- PROCEDURE Pulmonary function test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-04-30 |
| Est. Completion | 2023-02-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04247971
The ClinicalTrials.gov registry entry for NCT04247971 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT04247971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04247971 about?
NCT04247971 is a clinical study titled "Pulmonary Inflammation and Microbiome Changes With Bariatric Surgery in Obese Asthma". The purpose of this study is to gain understanding of mechanisms whereby bariatric surgery modulates pulmonary inflammation and pulmonary microbiome composition and how these changes direct the pathobiology of human obese asthma.
What is the current status of trial NCT04247971?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2021-04-30. Estimated completion is 2023-02-09.
What interventions are being tested in trial NCT04247971?
The interventions under investigation include: Blood draw (PROCEDURE), Sputum collection (PROCEDURE), Pulmonary function test (PROCEDURE).
Who is sponsoring clinical trial NCT04247971?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.